Overview

Management of bladder cancer provides a single, comprehensive reference source that incorporates all the latest information regarding bladder cancer. The text covers epidemiology and natural history of bladder cancer as well as latest findings regarding the genetics and molecular biology of the disease. Diagnostic and staging evaluation of both non-muscle invasive and invasive bladder cancer is discussed. The text incorporates chapters summarizing new findings regarding markers for the diagnosis of bladder cancer and new diagnostic techniques to enhance traditional methods such as cystoscopy. Risk stratified treatment of non muscle invasive bladder cancer including various approaches to intravesical therapy are reviewed. Current guideline based approaches to management and new data regarding diagnosis and prognostication of muscle invasive bladder cancer is analyzed and summarized. The application of chemotherapy for muscle invasive and advanced disease is discussed and the evidence based application of multimodality therapy highlighted. Finally, gaps in current knowledge and areas for future research are highlighted. Ongoing important clinical trials which could imminently yield significant new knowledge is discussed. Authored by experts in their respective fields, Management of Bladder Cancer will serve as a easy and complete reference source for clinicians, researchers, individuals in training, allied health professionals and medical students in the fields of Urology, Medical Oncology, Radiation Oncology, Basic and Translational Science and Epidemiology.

Full Product Details

Author:   Badrinath R. Konety ,  Sam S. Chang, M.D.
Publisher:   Springer-Verlag New York Inc.
Imprint:   Springer-Verlag New York Inc.
Edition:   2015 ed.
Dimensions:   Width: 17.80cm , Height: 2.70cm , Length: 25.40cm
Weight:   1.221kg
ISBN:  

9781493918805

ISBN 10:   149391880
Pages:   479
Publication Date:   17 November 2014
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.
Language:   English

Table of Contents

I.                   GENERAL CONCEPTS   1.      Epidemiology and natural history Edward Messing and Emil Scosyrev   2.      Screening for Bladder Cancer Laura-Maria Krabbe, Robert S. Svatek and Yair Lotan   3.      Pathology and Staging: Histopathology and Cytopathology Amber Mackey, Farnaz Hasteh and Donna E. Hansel   4.      Pathology and Staging: Genetics and Molecular Biology Sean McAdams and Michael C. Risk   5.      Imaging in Localized and Advanced Bladder Cancer Timothy Kim, Joshua G. Griffin, Jeffrey M. Holzbeierlein and Wade J. Sexton   6.      New Imaging Techniques in Staging of Urothelial Carcinoma of the Bladder Ramdev Konijeti and Adam S. Kibel   7.      Socioeconomic issues and improved quality of care John L. Gore   8.      Quality of life measures Christopher B. Anderson, David F. Penson and Daniel A. Barocas   9.      Prognostication and risk assessment Luis Alex Kluth, Bernie Bochner and Shahrokh F. Shariat   10.  Clinical trials and emerging therapeutic strategies in bladder cancer Richard M. Bambury, Robert B. Sims and Jonathan E. Rosenberg     II.                NON MUSCLE INVASIVE BLADDER CANCER   11.  Improved diagnostic techniques Seth P. Lerner and Alvin C. Goh   12.  Clinical scenario: Microscopic hematuria and atypical cytology in a 68 year old man with normal upper tract imaging Christopher S. Gomez, Mark S. Soloway, Jorge Caso, Claudia P. Rojas and Merce Jorda   13.  Localized surgical therapy and surveillance Manish I. Patel and Paul D. Sved   14.  Clinical Scenario: Initial high grade Ta tumor Jose L. Dominguez-Escrig and Eduardo Solsona Narbón   15.  Clinical Scenario: Recurrent Ta tumor Joseph A. Gillespie and Michael A. O'Donnell   16.  Clinical Scenario: Rapidly growing, high volume, low grade Ta tumor James S. Rosoff and Thomas A. Keane   17.  Clinical Scenario: Low grade T1 tumor J. Alfred Witjes and Florine W.M. Schlatmann   18.  Intravesical therapy Jennifer J. Ahn and James M. McKiernan   19.  Clinical Scenario: Initial CIS Sima P. Porten and Colin P. Dinney   20.  Management of BCG Recurrent Bladder Cancer Tracy M. Downs, Daniel J. Lee and Douglass S. Scherr   21.  Clinical Scenario: Persistent CIS and HIGH Grade Ta Bladder Cancer after BCG Maurizio Brausi   22.  Clinical Scenario: Presentation and Management of Significant Side Effects from Bacillus Calmette-Guérin Bladder Instillation Donald L. Lamm and Nilay M. Gandhi   23.  Guideline-based management of non-muscle invasive bladder cancer: comparison of the AUA, EAU, ICUD and NCCN guidelines Jeffrey C. Bassett, John D. Seigne and Peter E. Clark     III.             MUSCLE INVASIVE BLADDER CANCER   24.  Open Radical Cystectomy J. Joy Lee, Dipen J. Parekh and Mark L. Gonzalgo   25.  Robotic cystectomy Michael Woods, Raj Pruthi and Erik P. Castle   26.  Clinical Scenario: T2 bladder tumor Richard E. Hautmann   27.  Urinary Diversion: Open and robotic techniques Norm D. Smith, Gary D. Steinberg and Cheryl T. Lee   28.  Chemoradiotherapy Christian Weiss and Claus Rödel   29.  Clinical Scenario: 53 year-old man with a solitary, 2 cm, high-grade T2 tumor and focal CIS in the bladder dome who wants bladder preservation Albert J. Chang, Maurice Marcel Garcia and Mack Roach III   30.  Management of Bladder Cancer, role of chemotherapy and controversies surrounding its application Gautam Jha, Guru Sonpavde and Zeeshan Ahmad   31.  Clinical Scenario: Large volume, non metastatic T2 bladder tumor Chad R. Ritch and Michael S. Cookson   32.  The role of pelvic lymphadenectomy at the time of radical cystectomy for bladder cancer Samuel D. Kaffenberger, Todd M. Morgan and Anne K. Schuckman   33.  Clinical Scenario: Unexpected positive nodes at radical cystectomy Christian Thomas and Joachim W. Thüroff   34.  Surveillance and monitoring Daniel J. Canter, Joseph Zabell, Stephen A. Boorjian and Christopher J. Weight   35.  Clinical Scenario: The Role of Perioperative Chemotherapy Eila C. Skinner   36.  Management of Bladder Cancer with Pelvic Nodal Metastases After Complete Response to Chemotherapy Adam C. Reese and Mark P. Schoenberg   37.  Guideline based management muscle-invasive bladder cancer: NCCN, ICUD and EAU Amanda N. Calhoun and Kamal S. Pohar

Reviews

From the book reviews: The target audience is researchers, clinicians, trainees, allied health professionals, and medical students. Given the emphasis and specificity of the chapters on early stage bladder cancer, this book seems most geared to urologists and urology trainees. ... This is a very easy to use, clearly and expertly written, case- and clinical scenario-based reference that will be helpful to all who treat and study bladder cancer. (Jean Hoffman-Censits, Doody's Book Reviews, March, 2015)

Author Information

Badrinath R. Konety, MD, MBA, FACS Professor and Chair, Dept. of Urology Dougherty Family Chair in Urologic Oncology Associate Director for Clinical Affairs, Masonic Cancer Center University of Minnesota MMC 394, 420 Delaware St Minneapolis MN 55455, USA   Sam S. Chang, MD, FACS Professor of Urologic Surgery Patricia and Rodes Hart Chair of Urologic Surgery Department of Urologic Surgery Vanderbilt University Medical Center MCN A 1302, VUMC Nashville, TN 37232, USA

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions